Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Colon Cancer
• Hepatocellular Carcinoma
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• GC001 (oncolytic vaccinia virus GC001)

Snippet

Sponsor: GONGCHU Biotechnology Co., Ltd | Conditions: Sarcoma, Cervical Cancer | Phase 1 | Status: RECRUITING